Search

everythinglearnresearchcommunity

for

Search:↓

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Both drugs lower DHT levels, with GI198745 being more effective.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

A new compound may treat benign prostatic hyperplasia better than finasteride.

JAK inhibitors are effective treatments for alopecia areata.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Some gonadal hormone drugs can block filovirus entry into cells.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

JAK inhibitors are effective for long-term management of alopecia areata.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Blocking TRPV3 may help treat itch in dry skin conditions.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

DA-9401 helps protect rat testis from finasteride damage.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.